18h
ThePrint on MSNHow Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted ...
Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...
Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results